Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses-Reference-Cited by-同舟云学术

Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses

Published:2013-11-18 Issue:7 Volume:209 Page:995-1006
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Agnihothram Sudhakar,Gopal Robin,Yount Boyd L.,Donaldson Eric F.,Menachery Vineet D.,Graham Rachel L.,Scobey Trevor D.,Gralinski Lisa E.,Denison Mark R.,Zambon Maria,Baric Ralph S.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/209/7/995/13804699/jit609.pdf

Reference42 articles.

1. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission;Graham;J Virol,2010

2. The molecular biology of coronaviruses;Masters;Adv Virus Res,2006

3. Culturing the unculturable: human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures;Pyrc;J Virol,2010

4. Identification of a new human coronavirus;van der Hoek;Nat Med,2004

5. Characterization of a novel coronavirus associated with severe acute respiratory syndrome;Rota;Science,2003

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus nucleocapsid-based vaccine provides partial protection against hetero-species coronavirus in murine models;Antiviral Research;2024-11

2. Immunological storm and multiple organ damage by COVID-19;Medicine in Omics;2024-08

3. Different Neutralizing Antibody Responses of Heterologous Sera on Sheeppox and Lumpy Skin Disease Viruses;Viruses;2024-07-14

4. Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase;Antiviral Research;2023-10

5. Application of self-amplifying mRNA technology in the development of infectious disease vaccines;Chinese Science Bulletin;2023-10-01